| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |